Thus any effect that MIC-1/GDF15 has on local tumor biology, particularly tumor spread is likely to impact most cancer patients, raising the prospect that modulation of MIC-1/GDF15 actions during therapy might reduce the risk of metastatic disease and other complications of cancer. The gene discussed is GDF15; the disease is cancer.